Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Alx Oncology Holdings (ALXO) Return on Equity (2020 - 2026)

Alx Oncology Holdings' Return on Equity history spans 4 years, with the latest figure at 0.0% for Q4 2023.

  • On a quarterly basis, Return on Equity changed 0.0% to 0.0% in Q4 2023 year-over-year; TTM through Dec 2023 was 0.0%, a 0.0% change, with the full-year FY2023 number at 0.01%, down 1.0% from a year prior.
  • Return on Equity hit 0.0% in Q4 2023 for Alx Oncology Holdings, up from 0.0% in the prior quarter.
  • Over the last five years, Return on Equity for ALXO hit a ceiling of 0.0% in Q2 2020 and a floor of 0.0% in Q3 2020.
  • Historically, Return on Equity has averaged 0.0% across 4 years, with a median of 0.0% in 2023.
  • The widest YoY moves for Return on Equity: up 0bps in 2021, down 0bps in 2021.
  • Tracing ALXO's Return on Equity over 4 years: stood at 0.0% in 2020, then plummeted by -397bps to 0.0% in 2021, then skyrocketed by 44bps to 0.0% in 2022, then plummeted by -73bps to 0.0% in 2023.
  • Business Quant data shows Return on Equity for ALXO at 0.0% in Q4 2023, 0.0% in Q3 2023, and 0.0% in Q2 2023.